Table 3. Global Proportion of Individuals With at Least 1 of the 3 Long COVID Symptom Clusters.
Proportion with Long COVID symptom clusters among survivors, % (95% UI)a | ||
---|---|---|
3 mo after symptom onset | 12 mo after symptom onset | |
All individuals | 6.2 (2.4-13.3) | 0.9 (0.3-2.0)b |
Both sexes aged <20 yc | 2.8 (0.9-7.0) | 0.3 (0.1-0.8) |
Women aged ≥20 y | 10.6 (4.3-22.2) | 1.7 (0.7-3.6) |
Men aged ≥20 y | 5.4 (2.2-11.7) | 0.8 (0.3-1.8) |
Hospitalized | ||
Needed care in a general hospital ward | 27.5 (12.1-47.8) | 11.1 (4.7-19.7) |
Females | 34.8 (16.5-57.3) | 15.1 (5.8-29.7) |
Males | 21.6 (8.9-40.3) | 8.2 (2.9-17.7) |
Needed care in an ICU | 43.1 (22.6-65.2) | 20.5 (9.8-32.9) |
Females | 51.9 (29.7-73.6) | 26.6 (11.5-47.8) |
Males | 35.8 (17.1-58.1) | 15.7 (6.0-31.9) |
Not hospitalized | ||
All individuals | 5.7 (1.9-13.1) | 0.7 (0.2-1.5) |
Both sexes aged <20 yc | 2.7 (0.8-6.7) | 0.3 (0-0.8) |
Women aged ≥20 y | 9.9 (3.4-21.2) | 1.3 (0.3-3.4) |
Men aged ≥20 y | 4.8 (1.5-11.3) | 0.6 (0.1-1.5) |
Abbreviations: ICU, intensive care unit; UI, uncertainty interval.
Long COVID was defined as having at least 1 of the 3 symptom clusters (persistent fatigue with bodily pain or mood swings; cognitive problems; or ongoing respiratory problems) 3 months after symptomatic SARS-CoV-2 infection. Additional details appear in eTables 14-16 in Supplement 1.
Among individuals with Long COVID symptoms 3 months after symptomatic SARS-CoV-2 infection, 15.1% (95% UI, 10.3%-21.2%) continued to experience symptoms at 12 months.
Data were insufficient to stratify proportion estimates by sex.